Badolo L, Hanocq M, Dubois J
Laboratoire de Chimie Bioanalytique, de Toxicologie et de Chimie Physique Appliquée, Institut de Pharmacie, Université Libre de Bruxelles, Belgium.
Cell Biol Toxicol. 1998 Dec;14(6):419-28. doi: 10.1023/a:1007503928993.
The effects of a series of bisbenzyldiamine analogs have been tested on P388D1 cell line in vitro. Their effects on cell growth, polyamine oxidase (PAO) activity and intracellular polyamine content were determined. The cytotoxicity tests were performed in culture medium supplemented with 100 micromol/L aminoguanidine (I), 100 micromol/L aminoguanidine and 100 micromol/L N,N'-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72,527) (II), and finally 100 micromol/L aminoguanidine and 200 micromol/L D,L-difluoromethylornithine (DFMO) (III). The IC50 values under conditions I and III were similar, suggesting that inhibition of ornithine decarboxylase by DFMO did not affect the biological effect of our derivatives. Spermine and spermidine remained nontoxic in conditions I and III. However in the condition II, the toxicity of all tested compounds (excepted spermidine) was increased, suggesting that the inhibition of cellular PAO increased their toxicity. The enzymatic test of PAO showed that at high doses inhibition of this enzyme by putrescine analogs occurred, while the N-methylated propanediamine derivative increased the enzyme activity; however, these results do not correlate with cytotoxicity tests. When these derivatives were incubated for 48 h with the cells, all of them increased the cell content in putrescine (approximately 160%) and spermine (approximately 145%) and decreased the spermidine content (approximately 75%) without any modification of the total amount of polyamine. The correlation between the cytotoxic results and the intracellular polyamine determination shows that the increase in spermine content along with the inhibition of retroconverting PAO enzyme increases the toxic effect of tested compounds (including spermine), suggesting that spermine toxicity is more important in the absence of intracellular oxidation processes.
已在体外对P388D1细胞系测试了一系列双苄二胺类似物的效果。测定了它们对细胞生长、多胺氧化酶(PAO)活性和细胞内多胺含量的影响。细胞毒性试验在补充有100微摩尔/升氨基胍(I)、100微摩尔/升氨基胍和100微摩尔/升N,N'-双(2,3-丁二烯基)-1,4-丁二胺(MDL 72,527)(II)的培养基中进行,最后在补充有100微摩尔/升氨基胍和200微摩尔/升D,L-二氟甲基鸟氨酸(DFMO)(III)的培养基中进行。条件I和III下的IC50值相似,表明DFMO对鸟氨酸脱羧酶的抑制作用不影响我们衍生物的生物学效应。精胺和亚精胺在条件I和III下仍无毒性。然而在条件II下,所有测试化合物(亚精胺除外)的毒性均增加,表明细胞PAO的抑制增加了它们的毒性。PAO的酶试验表明,在高剂量下,腐胺类似物会抑制该酶,而N-甲基化丙二胺衍生物会增加酶活性;然而,这些结果与细胞毒性试验不相关。当这些衍生物与细胞一起孵育48小时时,它们均增加了腐胺(约160%)和精胺(约145%)的细胞含量,并降低了亚精胺含量(约75%),而多胺总量没有任何改变。细胞毒性结果与细胞内多胺测定之间的相关性表明,精胺含量的增加以及PAO逆转酶的抑制增加了测试化合物(包括精胺)的毒性,这表明在没有细胞内氧化过程的情况下,精胺毒性更为重要。